Alderley Park Ventures logo

Alderley Park Ventures

Europe, Nottingham, United Kingdom, Nottingham

Description

Alderley Park Ventures is a £5M seed investment fund managed by BioCity following a significant contribution by AstraZeneca.

Investor Profile

Alderley Park Ventures has made 7 investments, with 0 in the past 12 months and 29% as lead.

Stage Focus

  • Seed (57%)
  • Series Unknown (14%)
  • Series A (14%)
  • Pre Seed (14%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Pharmaceutical
  • Medical
  • Artificial Intelligence (Ai)
  • Data Integration
  • Enterprise Software
  • Information Technology
  • Paas
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alderley Park Ventures frequently co-invest with?

GM&C Life Sciences Fund
Europe, Cheshire, United Kingdom, Alderley Edge
Co-Investments: 2
Longwall Venture
Europe, Oxfordshire, United Kingdom, Harwell
Co-Investments: 1
BG
Europe, Nottingham, United Kingdom, Nottingham
Co-Investments: 3
Puffin Point
Europe, England, United Kingdom, London
Co-Investments: 1
TF
Europe, England, United Kingdom, London
Co-Investments: 1
Business Growth Fund
Europe, England, United Kingdom, London
Co-Investments: 1
Catapult Ventures
Europe, Leicester, United Kingdom, Enderby
Co-Investments: 2
Development Bank of Wales
Europe, Cardiff, United Kingdom, Cardiff
Co-Investments: 1
Praetura Ventures
Europe, Manchester, United Kingdom, Manchester
Co-Investments: 1

What are some of recent deals done by Alderley Park Ventures?

Maxwellia

Alderley, Cheshire, United Kingdom

Maxwellia is a pioneering ‘prescription to over the counter’ medicines company.

BiopharmaHealth CarePharmaceutical
Series UnknownApr 8, 2021
Amount Raised: $4,394,753
Kinomica

Alderley Park, Cheshire, United Kingdom

Kinomica is a proteomic-data science and diagnostics company specialising in cell signalling.

BiopharmaBiotechnology
Series ADec 14, 2020
Amount Raised: $5,197,062
BiVictriX Therapeutics

Alderley Edge, Cheshire, United Kingdom

Biotech is a biotechnology company that develops cancer therapies.

BiotechnologyLife SciencePharmaceuticalTherapeutics
SeedAug 19, 2019
GENXT

Hinxton, Cambridgeshire, United Kingdom

GENXT.AI develops B2B solutions that streamline enterprise AI adoption, eliminating the risks of private data and ML model disclosure.

Artificial Intelligence (AI)Data IntegrationEnterprise SoftwareInformation TechnologyPaaSPrivacySecurity
Pre SeedJan 24, 2019
Amount Raised: $65,600
Nexus Labs (Surgical Teaching)

Chester, Cheshire, United Kingdom

Nexus Labs is an interactive learning resource for medical students.

E-LearningMedical
SeedAug 2, 2018
metaLinear

Alderley Edge, Cheshire, United Kingdom

metaLinear focuses on the identification and validation of new drug targets for difficult to treat bacterial infections.

BiotechnologyHealth CareMedical
SeedNov 23, 2017
Amount Raised: $339,297
Absynth Biologics

Sheffield, Sheffield, United Kingdom

Absynth Biologics develops treatments to prevent immunological diseases and therapies to combat bacterial infections.

BiotechnologyHealth Care
SeedNov 30, 2015
Amount Raised: $376,522